Handelsbanken Fonder’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.12M | Hold |
21,000
| – | – | ﹤0.01% | 912 |
|
|
2025
Q1 | $850K | Hold |
21,000
| – | – | ﹤0.01% | 1003 |
|
|
2024
Q4 | $584K | Buy |
21,000
+1,000
| +5% | +$27.8K | ﹤0.01% | 1228 |
|
|
2024
Q3 | $574K | Buy |
20,000
+2,200
| +12% | +$63.1K | ﹤0.01% | 1192 |
|
|
2024
Q2 | $418K | Buy |
17,800
+8,000
| +82% | +$188K | ﹤0.01% | 1231 |
|
|
2024
Q1 | $248K | Hold |
9,800
| – | – | ﹤0.01% | 1443 |
|
|
2023
Q4 | $229K | Buy |
9,800
+300
| +3% | +$7.01K | ﹤0.01% | 1482 |
|
|
2023
Q3 | $481K | Hold |
9,500
| – | – | ﹤0.01% | 1072 |
|
|
2023
Q2 | $444K | Buy |
9,500
+2,600
| +38% | +$122K | ﹤0.01% | 1135 |
|
|
2023
Q1 | $264K | Hold |
6,900
| – | – | ﹤0.01% | 1345 |
|
|
2022
Q4 | $378K | Buy |
+6,900
| New | +$378K | ﹤0.01% | 1115 |
|